Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJ-12420 in erosive esophagitis
NCT02028663Phase 2Completed
- Sponsor
- HK inno.N Corporation
- Start
- May 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegoprazan in erosive esophagitis (EE), gastroesophageal reflux disease (GERD), sponsored by HK inno.N Corporation. Started May 2013; status: completed.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02028663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028663.